Yes, glycosylation patterns can serve as biomarkers for various diseases, including cancer, diabetes, and congenital disorders of glycosylation (CDGs). Aberrant glycosylation is often observed in cancer cells, where it can affect tumor progression and metastasis. Identifying specific glycosylation patterns can aid in the diagnosis and prognosis of these conditions.
